Spots Global Cancer Trial Database for iclusig®
Every month we try and update this database with for iclusig® cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Iclusig® (Ponatinib) in Clinical Practice for the Treatment of Chronic Myeloid Leukemia or Ph+ Acute Lymphoblastic Leukemia in Belgium | NCT03678454 | Chronic Myeloid... CML Philadelphia Ch... Ph+ ALL | 18 Years - | Incyte Corporation | ||
Iclusig® (Ponatinib) in Clinical Practice for the Treatment of Chronic Myeloid Leukemia or Ph+ Acute Lymphoblastic Leukemia in Belgium | NCT03678454 | Chronic Myeloid... CML Philadelphia Ch... Ph+ ALL | 18 Years - | Incyte Corporation |